CY1108138T1 - Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι - Google Patents
Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιιInfo
- Publication number
- CY1108138T1 CY1108138T1 CY20081100628T CY081100628T CY1108138T1 CY 1108138 T1 CY1108138 T1 CY 1108138T1 CY 20081100628 T CY20081100628 T CY 20081100628T CY 081100628 T CY081100628 T CY 081100628T CY 1108138 T1 CY1108138 T1 CY 1108138T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- conglutin gamma
- lupin conglutin
- lupinoconglutine
- lupin
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 abstract 5
- 101710155000 Gamma conglutin 1 Proteins 0.000 abstract 5
- 241000219745 Lupinus Species 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Diabetes (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αποκαλύπτει τη χρησιμοποίηση γάμμα λουπινοκονγλουτίνης ή πρωτεϊνών οι οποίες παρουσιάζουν ομολογία ανωτέρα του 50% με την γάμμα λουπινοκονγλουτίνη δια την παρασκευή ενός φαρμάκου, συμπληρωμάτων τροφίμων ή τροφίμων δια την θεραπευτική αγωγή διαβήτου τύπου II. Φάρμακα και συμπληρώματα τροφίμων που περιέχουν γάμμα λουπινοκονγλουτίνη και τη χρησιμοποίηση γάμμα λουπινοκονγλουτίνης ως θεραπευτικού παράγοντος και ειδικότερα ως παράγοντος υπογλυκοποιήσεως. Η γάμμα λουπινοκονγλουτίνη μπορεί να χρησιμοποιηθεί υπό καθαρά μορφή ή υπό μορφή εκχυλισμάτων, μειγμάτων ή συμπυκνωμάτων.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000237A ITMI20030237A1 (it) | 2003-02-11 | 2003-02-11 | Uso della conglutina di lupino per il trattamento del |
| EP04708771A EP1605957B1 (en) | 2003-02-11 | 2004-02-06 | The use of lupin conglutin for the treatment of type ii diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1108138T1 true CY1108138T1 (el) | 2014-02-12 |
Family
ID=32866063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100628T CY1108138T1 (el) | 2003-02-11 | 2008-06-12 | Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7323441B2 (el) |
| EP (1) | EP1605957B1 (el) |
| JP (2) | JP2006517212A (el) |
| KR (2) | KR101084434B1 (el) |
| CN (1) | CN1747739B (el) |
| AT (1) | ATE391510T1 (el) |
| AU (1) | AU2004212297B2 (el) |
| CA (1) | CA2515607C (el) |
| CY (1) | CY1108138T1 (el) |
| DE (1) | DE602004012984T2 (el) |
| DK (1) | DK1605957T3 (el) |
| ES (1) | ES2303937T3 (el) |
| HK (1) | HK1085927A1 (el) |
| IL (1) | IL170200A (el) |
| IT (1) | ITMI20030237A1 (el) |
| NO (1) | NO333224B1 (el) |
| PL (1) | PL214193B1 (el) |
| PT (1) | PT1605957E (el) |
| RU (1) | RU2339393C2 (el) |
| SI (1) | SI1605957T1 (el) |
| WO (1) | WO2004071521A1 (el) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20030237A1 (it) * | 2003-02-11 | 2004-08-12 | Indena Spa | Uso della conglutina di lupino per il trattamento del |
| DK2310037T3 (da) | 2008-05-30 | 2014-10-27 | Policlinico San Donato S P A Istituto Di Ricovero E Cura A Carattere Scient | Conglutin-gamma as-medikament og -kosttilskudpatentkrav |
| EP2411137B1 (en) | 2009-03-27 | 2016-09-07 | Bend Research, Inc. | Spray-drying process |
| US9084976B2 (en) | 2010-09-03 | 2015-07-21 | Bend Research, Inc. | Spray-drying apparatus and methods of using the same |
| WO2012031133A2 (en) | 2010-09-03 | 2012-03-08 | Bench Research, Inc. | Spray-drying apparatus and methods of using the same |
| US9248584B2 (en) | 2010-09-24 | 2016-02-02 | Bend Research, Inc. | High-temperature spray drying process and apparatus |
| CN110227145B (zh) | 2010-10-12 | 2024-04-02 | 肯苏墨艾姆维德-生物技术达思植物有限公司 | 抗菌蛋白 |
| ES2989360T3 (es) | 2014-06-30 | 2024-11-26 | Prolupin Gmbh | Emulsión con proteína de lupino, uso y producción de la misma |
| US11364203B2 (en) | 2014-10-31 | 2022-06-21 | Bend Reserch, Inc. | Process for forming active domains dispersed in a matrix |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU66892A (sh) * | 1991-08-20 | 1995-10-24 | Hoechst Ag. | Fosfoinositolglikan - peptid sa delovanjem kao insulin |
| JPH08127538A (ja) * | 1994-10-31 | 1996-05-21 | Masakiyo Takahashi | 糖尿病治療薬 |
| JPH0967252A (ja) * | 1995-09-05 | 1997-03-11 | Zenkoku Royal Jelly Kosei Torihiki Kiyougikai | ローヤルゼリーに含まれるトランス−１０−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤 |
| ITMI20030237A1 (it) * | 2003-02-11 | 2004-08-12 | Indena Spa | Uso della conglutina di lupino per il trattamento del |
-
2003
- 2003-02-11 IT IT000237A patent/ITMI20030237A1/it unknown
-
2004
- 2004-02-06 US US10/545,103 patent/US7323441B2/en not_active Expired - Lifetime
- 2004-02-06 RU RU2005125411/15A patent/RU2339393C2/ru not_active IP Right Cessation
- 2004-02-06 CN CN2004800039114A patent/CN1747739B/zh not_active Expired - Fee Related
- 2004-02-06 AU AU2004212297A patent/AU2004212297B2/en not_active Ceased
- 2004-02-06 DE DE602004012984T patent/DE602004012984T2/de not_active Expired - Lifetime
- 2004-02-06 KR KR1020057014390A patent/KR101084434B1/ko not_active Expired - Fee Related
- 2004-02-06 PT PT04708771T patent/PT1605957E/pt unknown
- 2004-02-06 WO PCT/EP2004/001111 patent/WO2004071521A1/en active IP Right Grant
- 2004-02-06 AT AT04708771T patent/ATE391510T1/de active
- 2004-02-06 PL PL377578A patent/PL214193B1/pl unknown
- 2004-02-06 SI SI200430714T patent/SI1605957T1/sl unknown
- 2004-02-06 EP EP04708771A patent/EP1605957B1/en not_active Expired - Lifetime
- 2004-02-06 JP JP2006501760A patent/JP2006517212A/ja not_active Withdrawn
- 2004-02-06 DK DK04708771T patent/DK1605957T3/da active
- 2004-02-06 KR KR1020117005984A patent/KR20110033312A/ko not_active Withdrawn
- 2004-02-06 CA CA2515607A patent/CA2515607C/en not_active Expired - Fee Related
- 2004-02-06 ES ES04708771T patent/ES2303937T3/es not_active Expired - Lifetime
-
2005
- 2005-08-10 IL IL170200A patent/IL170200A/en active IP Right Grant
- 2005-08-10 NO NO20053788A patent/NO333224B1/no not_active IP Right Cessation
-
2006
- 2006-05-25 HK HK06106013.4A patent/HK1085927A1/xx not_active IP Right Cessation
-
2008
- 2008-06-12 CY CY20081100628T patent/CY1108138T1/el unknown
-
2012
- 2012-04-26 JP JP2012100564A patent/JP5504301B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108138T1 (el) | Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι | |
| MXPA05009933A (es) | Composiciones que comprenden acidos grasos y aminoacidos. | |
| MX2008004734A (es) | Composicion rica en leucina. | |
| WO2001028356A3 (en) | Food supplement for increasing lean mass and strength | |
| BR0308799A (pt) | co-glóbulos de dha e alecrim e método de uso | |
| WO2007002836A3 (en) | Methods and compositions for the prevention and treatment of kidney disease | |
| MXPA02011476A (es) | Fuente de triptofano de plantas y usos para el mismo. | |
| DE60012301D1 (de) | Lipoproteinkomplexe und zusammensetzungen, die diese enthalten | |
| BR0308713A (pt) | Co-esférula de dha e alecrim, e métodos de uso | |
| IL172916A0 (en) | Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance | |
| TW200513197A (en) | Amino acid supplementation for a healthy microbiota ecosystem | |
| WO2002089741A3 (en) | Compositions and methods for enhancing drug delivery | |
| AR045745A1 (es) | Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2 | |
| TW200501973A (en) | Method of improvement of blood circulation | |
| IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
| DK1497250T3 (da) | Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse | |
| FR2838645B1 (fr) | Nouvelles compositions synergiques de vitamines, de mineraux et d'oligo-elements pour stimuler l'elimination des lipides intracellulaires | |
| JP2017043593A (ja) | 黒ニンニク及びビタミンｂ１を含有する組成物 | |
| PH12022552816A1 (en) | Methods of increasing microvascular blood flow | |
| NZ512402A (en) | Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale | |
| LT2001072A (lt) | Maisto papildas | |
| JP2003335685A (ja) | ミネラルバランス健康法 | |
| MD1780F1 (en) | Method of treatment of patients with hepatic cirrhosis | |
| LT2001054A (lt) | Propolio tepalas | |
| TH87926A (th) | โภชนาการสำหรับผู้ป่วยอ้วนเกิน |